Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback